Guardant Health 10K Form
7 Day Trial
ALL ACCESS PASS
10K form not available
Receive GH News And Ratings
See the #1 stock for the next 7 days that we like better than GH
GH Financial Statistics
Sales & Book Value
|Price / Cash Flow:||0|
|Price / Book:||45.29|
|Net Income (TTM):||$-654.59M|
|Return on Equity:||-189.84%|
|Return on Assets:||-34.45%|
Guardant Health Earnings Forecast
Key Guardant Health Financial Ratios
- The Gross Profit Margin over the past 7 years for GH is 65.22%.
- The Selling, General & Administrative Expenses for GH have been equal to 103.17% of Gross Profit Margin.
- The Research & Development expenses have been 83.15% of Revenue.
- The Interest Expense is -0.39% of Operating Income.
- The Net Earning history of GH is -145.61% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 1 years.
Guardant Health Stock Price Chart
Industry, Sector and Symbol
|Industry:||Diagnostics & Research|
|Trailing P/E Ratio:||0|
|Forward P/E Ratio:||0|
GH Technical Analysis vs Fundamental Analysis
Guardant Health (GH) is a Sell
Is Guardant Health a Buy or a Sell?
Guardant Health stock is rated a Sell
The current Guardant Health [GH] share price is $26.55. The Score for GH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.